A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

NCT07348237 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Failure
End-Stage Renal Disease
Renal Impairment

Interventions

DRUG: MK-2828

Sponsor

Merck Sharp & Dohme LLC